American Association for Cancer Research

SHERPA: Unknown

People

  1. Selenica
    Selenica
  2. Weigelt
    Weigelt
  3. Pareja Zea
    Pareja Zea
  4. Wen
    Wen
  5. Chandarlapaty
    Chandarlapaty
  6. Robson
    Robson
  7. Brogi
    Brogi
  8. Mandelker
    Mandelker
  9. Razavi
    Razavi
  10. Norton
    Norton

Groups

  1. GSK Faculty (29)
  2. Department of Pathology and Laboratory Medicine (28)
  3. GDMT, Pathology and Laboratory Medicine (27)
  4. Gynecology Disease Management Team (27)
  5. Sloan Kettering Institute Postdocs (25)
  6. Department of Medicine (20)
  7. Solid Tumor Oncology Division (20)
  8. Breast Medicine Service (16)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (12)
  10. Hematology-Oncology Fellows (11)
Search Within
  1. "Pier Selenica"
Formats
  1. Meeting Abstract (16)
  2. Journal Article (14)
Groups
  1. GSK Faculty (29)
  2. Department of Pathology and Laboratory Medicine (28)
  3. GDMT, Pathology and Laboratory Medicine (27)
  4. Gynecology Disease Management Team (27)
  5. Sloan Kettering Institute Postdocs (25)
  6. Department of Medicine (20)

More Groups

People
  1. Pier Selenica (30)
  2. Jorge Reis-Filho (28)
  3. Britta Weigelt (27)
  4. Fresia Pareja Zea (12)
  5. David Brown (10)
  6. Arnaud Da Cruz Paula (8)

More People

Years
  1. 2025 (2)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (4)
  5. 2021 (2)
  6. 2020 (12)

More Years

Publications
  1. Cancer Research (19)
  2. Clinical Cancer Research (11)

Results (30)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinicopathologic features, molecular landscape, and prognostic implications of ovarian low-grade serous tumors with histologic transformation
    Journal Article

    Chui, M. H.; Kang, E. Y.; Kahn, R. M.; Chiang, S.; Zhou, Q.; Iasonos, A.; Manning-Geist, B.; Selenica, P.; Da Cruz Paula, A.; Long Roche, K.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant plus abemaciclib in hormone receptor–positive advanced or recurrent endometrial cancer
    Journal Article

    Green, A. K.; Zhou, Q.; Iasonos, A.; Zammarrelli, W. A. 3rd; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Loh, J.; Hom, V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • A genomics-driven artificial intelligence–based model classifies breast invasive lobular carcinoma and discovers CDH1 inactivating mechanisms
    Journal Article

    Pareja, F.; Dopeso, H.; Wang, Y. K.; Gazzo, A. M.; Brown, D. N.; Banerjee, M.; Selenica, P.; Bernhard, J. H.; Derakhshan, F.; da Silva, E. M.; more...
    Cancer Research (2024)

    Fulltext@MSK | Save
  • A Multiparameter molecular classifier to predict response to neoadjuvant lapatinib plus trastuzumab without chemotherapy in HER2+ breast cancer
    Journal Article

    Veeraraghavan, J.; Gutierrez, C.; De Angelis, C.; Davis, R.; Wang, T.; Pascual, T.; Selenica, P.; Sanchez, K.; Nitta, H.; Kapadia, M.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • High-sensitivity mutation analysis of cell-free DNA for disease monitoring in endometrial cancer
    Journal Article

    Ashley, C. W.; Selenica, P.; Patel, J.; Wu, M.; Nincevic, J.; Lakhman, Y.; Zhou, Q.; Shah, R. H.; Berger, M. F.; Da Cruz Paula, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • The role of EGFR in resistance to tucatinib and its therapeutic implications
    Meeting Abstract

    Veeraraghavan, J.; Liao, F. T.; Gordon, T.; Selenica, P.; Nanda, S.; Qin, L.; Zhu, Y.; Patel, J. A.; Gazzo, A.; Stossi, F.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Single-cell DNA sequencing from frozen endometrial tumors to address clonal evolution of somatic mutations
    Meeting Abstract

    Da Cruz Paula, A.; Zhu, Y.; Bhaloo, S. I.; Pareja, F.; Hoang, T.; Selenica, P.; Hanlon, E.; Basili, T.; Dopeso, H.; Abu-Rustum, N.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Microsatellite instability-high endometrial cancers with MLH1 promoter hypermethylation have distinct molecular and clinical profiles
    Journal Article

    Manning-Geist, B. L.; Liu, Y. L.; Devereaux, K. A.; Da Cruz Paula, A.; Zhou, Q. C.; Ma, W.; Selenica, P.; Ceyhan-Birsoy, O.; Moukarzel, L. A.; Hoang, T.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Morphologic and genomic characteristics of breast cancers occurring in individuals with Lynch syndrome
    Journal Article

    Schwartz, C. J.; da Silva, E. M.; Marra, A.; Gazzo, A. M.; Selenica, P.; Rai, V. K.; Mandelker, D.; Pareja, F.; Misyura, M.; D'Alfonso, T. M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Activation of the IFN signaling pathway is associated with resistance to CDK4/6 inhibitors and immune checkpoint activation in ER-positive breast cancer
    Journal Article

    De Angelis, C.; Fu, X. Y.; Cataldo, M. L.; Nardone, A.; Pereira, R.; Veeraraghavan, J.; Nanda, S.; Qin, L. F.; Sethunath, V.; Wang, T.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: